Method for prevention of rejection and sever encapsulation of a supportive or functioning implant

US9681942B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9681942-B2
Application numberUS-60824909-A
CountryUS
Kind codeB2
Filing dateOct 29, 2009
Priority dateNov 7, 2001
Publication dateJun 20, 2017
Grant dateJun 20, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of preventing rejection of an implant in the eye, includes forming a flap in the cornea of the eye, inserting an implant under the flap, cross linking corneal tissue surrounding an implant to make the corneal tissue surrounding an implant less vulnerable to enzymatic degradation, inserting polymeric material under the corneal flap so as to overlie corneal tissue, compressing a layer of the cornea from outside using a lens having a predetermined curvature to correct refractive error of the cornea, and cross linking corneal tissue that the polymeric material overlies.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of preventing rejection of an implant in the eye, comprising: forming a flap in the cornea of the eye, wherein said forming a flap includes cutting the flap with one of a micro-keratome and a femto-second laser, the flap being cut so as to have a diameter between 2 mm-12 mm and a thickness of 50 microns to 400 microns; raising the flap so as to expose stromal tissue of the cornea; applying a cross linking material in the form of Riboflavin to the stromal tissue of the cornea under the flap; inserting an implant under the flap so as to overlie the stromal tissue of the cornea; covering at least a central portion of the implant with the flap; and after said inserting the implant under the flap, cross linking corneal tissue vulnerable to enzymatic degradation surrounding the implant to decrease the vulnerability of corneal tissue surrounding the implant to enzymatic degradation, to make the corneal tissue surrounding the implant less likely to be invaded by migrating cells, and to prevent encapsulation around the implant.

Assignees

Inventors

Classifications

  • characterised by electric heating · CPC title

  • using laser · CPC title

  • Cornea, e.g. artificial corneae, keratoprostheses or corneal implants for repair of defective corneal tissue · CPC title

  • Eye parts, e.g. lenses or corneal implants; Artificial eyes · CPC title

  • Correction of presbyopia · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9681942B2 cover?
A method of preventing rejection of an implant in the eye, includes forming a flap in the cornea of the eye, inserting an implant under the flap, cross linking corneal tissue surrounding an implant to make the corneal tissue surrounding an implant less vulnerable to enzymatic degradation, inserting polymeric material under the corneal flap so as to overlie corneal tissue, compressing a layer of…
Who is the assignee on this patent?
Peyman Gholam A
What technology area does this patent fall under?
Primary CPC classification A61F2/148. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).